What to Expect After a Zinplava Infusion: A Comprehensive Guide
•
3 min read
Zinplava (bezlotoxumab) is a human monoclonal antibody approved by the FDA to help reduce the recurrence of *Clostridioides difficile* infection (CDI) in high-risk adult patients. This medication is administered as a single, one-hour intravenous infusion during a course of antibacterial treatment for CDI. Knowing what to expect after a Zinplava infusion can help patients and their caregivers monitor for side effects and ensure a smoother recovery process.
